Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALB vs GSK✓SelectedUSD · GSKALB vs GSK performance historyLatest closeAs of-5.74%11/16
Stock and ETF performance explorer

ALB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-24.6%
GSK return
+64.4%
Excess return
-89.1%
Maximum drawdown
-66.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.7%-0.1%-5.7%-5.7%
7D-11.1%-1.3%-9.7%-10.8%
30D-7.7%+2.7%-10.4%-8.3%
3M-35.0%+2.7%-37.7%-35.5%
6M-50.8%+3.3%-54.2%-51.4%
YTD-37.1%+6.5%-43.6%-38.6%
1Y-22.6%+10.7%-33.2%-25.0%
3Y-24.6%+64.4%-89.0%-38.3%
All-24.6%+64.4%-89.1%-38.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling